Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yvonne Wollmann"'
Autor:
Chelsea McLean, Karin Dijkman, Auguste Gaddah, Babajide Keshinro, Michael Katwere, Macaya Douoguih, Cynthia Robinson, Laura Solforosi, Dominika Czapska-Casey, Liesbeth Dekking, Yvonne Wollmann, Ariane Volkmann, Maria Grazia Pau, Benoit Callendret, Jerry Sadoff, Hanneke Schuitemaker, Roland Zahn, Kerstin Luhn, Jenny Hendriks, Ramon Roozendaal
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIn the absence of clinical efficacy data, vaccine protective effect can be extrapolated from animals to humans, using an immunological biomarker in humans that correlates with protection in animals, in a statistical approach called immuno
Externí odkaz:
https://doaj.org/article/aad84e5ba566494dbfbc8dd3349ac928
Autor:
Kathrin Endt, Yvonne Wollmann, Jana Haug, Constanze Bernig, Markus Feigl, Alexander Heiseke, Markus Kalla, Hubertus Hochrein, Mark Suter, Paul Chaplin, Ariane Volkmann
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Respiratory syncytial virus (RSV) causes a respiratory disease with a potentially fatal outcome especially in infants and elderly individuals. Several vaccines failed in pivotal clinical trials, and to date, no vaccine against RSV has been licensed.
Externí odkaz:
https://doaj.org/article/ba116f6fd77346338803ea293d9d69ae
Autor:
Ramon Roozendaal, Jenny Hendriks, Thierry van Effelterre, Bart Spiessens, Liesbeth Dekking, Laura Solforosi, Dominika Czapska-Casey, Viki Bockstal, Jeroen Stoop, Daniel Splinter, Sarah Janssen, Ben van Baelen, Nadia Verbruggen, Jan Serroyen, Eline Dekeyster, Ariane Volkmann, Yvonne Wollmann, Ricardo Carrion, Luis D. Giavedoni, Cynthia Robinson, Maarten Leyssen, Macaya Douoguih, Kerstin Luhn, Maria Grazia Pau, Jerry Sadoff, An Vandebosch, Hanneke Schuitemaker, Roland Zahn, Benoit Callendret
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
Abstract It has been proven challenging to conduct traditional efficacy trials for Ebola virus (EBOV) vaccines. In the absence of efficacy data, immunobridging is an approach to infer the likelihood of a vaccine protective effect, by translating vacc
Externí odkaz:
https://doaj.org/article/31753f8ec19c4f7ca129201ac99ccb00
Autor:
Bart Spiessens, Ramon Roozendaal, Liesbeth Dekking, Maria Grazia Pau, Cynthia Robinson, Dominika N. Czapska-Casey, Yvonne Wollmann, Thierry Van Effelterre, Viki Bockstal, Eline Dekeyster, Roland Zahn, Jeroen N Stoop, Kerstin Luhn, Jan Serroyen, Luis D. Giavedoni, Jenny Hendriks, Sarah Janssen, Maarten Leyssen, Ben Van Baelen, Hanneke Schuitemaker, Ricardo Carrion, Daniel Splinter, An Vandebosch, Jerry Sadoff, Ariane Volkmann, Nadia Verbruggen, Macaya Douoguih, Laura Solforosi, Benoit Callendret
Publikováno v:
NPJ VACCINES
npj Vaccines
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
npj Vaccines
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
It has been proven challenging to conduct traditional efficacy trials for Ebola virus (EBOV) vaccines. In the absence of efficacy data, immunobridging is an approach to infer the likelihood of a vaccine protective effect, by translating vaccine immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a435e1265a441954725ed3930a761f9
http://hdl.handle.net/1887/3562934
http://hdl.handle.net/1887/3562934
Publikováno v:
Biochemical Journal. 409:169-177
TopBP1 (topoisomerase IIβ-binding protein 1) is a BRCT [BRCA1 (breast-cancer susceptibility gene 1) C-terminal]-domain-rich protein that is structurally and functionally conserved throughout eukaryotic organisms. It is required for the initiation of
Autor:
Yvonne Wollmann, Peter F. Zipfel, Hanspeter Saluz, Frank Hänel, Uta Schmidt, Gerhard D. Wieland
Publikováno v:
Journal of cellular biochemistry. 102(1)
We investigated the physical association of the DNA topoisomerase IIβ binding protein 1 (TopBP1), involved in DNA replication and repair but also in regulation of apoptosis, with poly(ADP-ribose) polymerase-1 (PARP-1). This enzyme plays a crucial ro
Publikováno v:
Biochemical Journal; 2008, Vol. 409 Issue 1, p169-177, 9p